Milonas D, Auskalnis S, Skulcius G, Gudinaviciene I, Jievaltas M and Joniau S. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial. World journal of urology. 2016....
Prostate cancer is the second most common cancer in men worldwide and a leading cause of mortality. Incidences continues to rise and vary substantially between populations. Although the prevalence of prostate cancer is relatively low in Vietnam, some hospital-based reports have shown an upward tren...
As our understanding of the genetic basis of prostate cancer susceptibility improves, increasing numbers of individuals will be diagnosed as having a high lifetime risk of developing the disease. For these men, preventive measures that mitigate this high genetic susceptibility are needed....
Conclusions In this large, long-term trial of male physicians, neither vitamin E nor C supplementation reduced the risk of prostate or total cancer. These data provide no support for the use of these supplements for the prevention of cancer in middle-aged and older men. Trial Registration clini...
According to the American Cancer Society, prostate cancer is the second most common cause of cancer-related mortality for US men. A continuing research challenge is to improve diagnosis (especially the ability to detect uncommon aggressive cancers) and improve chemoprevention (through nutrition and life...
The University of Delaware's Aditya Dutta and collaborators are investigating the NKX3.1 gene and its role in prostate cancer—the most common cancer and the second-leading cause of cancer-related death among men in the United States.
relatively slow growing.[2]Even so, prostate cancer can cause significant suffering because of such symptoms as urinary retention and bone pain. The risk of prostate cancer increases rapidly after age 50, and the tumor is especially prevalent in Western populations, particularly African-American men...
Use of multivitamins and prostate cancer mortality in a large cohort of US men. Cancer Causes Control. 2005;16(6):643-65016049802PubMedGoogle ScholarCrossref 11. Jacobs EJ, Connell CJ, Patel AV, et al. Multivitamin use and colon cancer mortality in the Cancer Prevention Study II cohort (...
690: Toremifene for the Prevention of Prostate Cancer Among 514 Men with High-Grade Prostatic Intraepithelial Neoplasia (PIN): Results of a Double-Blind, Placebo-Controlled Phase IIB Trial Prostate cancer is a common form of cancer affecting men worldwide. Pharmaceutical interventions, such as 5‐...
Se and prostate cancer prevention Prostate cancer is the second leading cause of cancer deaths in men, therefore it is increasingly important to understand its biology and epidemiology. New approaches for the primary and secondary prevention of prostate cancer are needed... MA Nelson,BW Porterfield,...